Baird lowered the firm’s price target on Genpact to $38 from $44 and keeps an Outperform rating on the shares. The firm said Q3 missed and 2023 guidance reduced on incremental pressure from short-cycle discretionary tech spending. Baird likes the valuation, but the pattern of steadiness has come into question a bit.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on G: